ANDO Y[au] - Search Results

Year	Number of Results
1955	1
1956	1
1959	2
1961	2
1962	1
1963	2
1964	2
1965	6
1966	1
1967	6
1968	1
1969	11
1970	5
1971	8
1972	2
1973	8
1974	9
1975	5
1976	9
1977	6
1978	12
1979	10
1980	16
1981	11
1982	21
1983	10
1984	13
1985	18
1986	28
1987	18
1988	25
1989	29
1990	18
1991	22
1992	30
1993	32
1994	35
1995	48
1996	51
1997	51
1998	54
1999	48
2000	48
2001	58
2002	63
2003	50
2004	53
2005	58
2006	64
2007	60
2008	72
2009	79
2010	96
2011	119
2012	105
2013	100
2014	111
2015	112
2016	101
2017	125
2018	112
2019	159
2020	129
2021	137
2022	144
2023	124
2024	122
2025	137
2026	110
2027	1

1

Progressive leptomeningeal involvement on gadolinium-enhanced FLAIR MRI in hereditary transthyretin amyloidosis with the V30M (p.V50M) mutation.

Misumi Y, Nomura T, Taguchi T, Yamakawa S, Uetani H, Tasaki M, Obayashi K, Yamashita T, Hirai T, Ando Y, Ueda M. Misumi Y, et al. Among authors: ando y. Amyloid. 2026 Jul 17:1-9. doi: 10.1080/13506129.2026.2702928. Online ahead of print. Amyloid. 2026. PMID: 42464809

2

Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.

Miyai Y, Shiraki Y, Ando R, Sugiyama D, Sato Y, Kato K, Asai N, Cao F, Nagao N, Tanabe K, Nakatochi M, Hase T, Chen-Yoshikawa TF, Kobayashi T, Iwama S, Esaki N, Mii S, Arima H, Kimura H, Takahashi M, Ando Y, Enomoto A. Miyai Y, et al. Among authors: ando y. Nat Commun. 2026 Jul 15. doi: 10.1038/s41467-026-75542-3. Online ahead of print. Nat Commun. 2026. PMID: 42457720 Free article.

3

Comprehensive genomic profiling and tumor mutational burden in parathyroid carcinoma: a nationwide real-world study from Japan.

Takano Y, Kikumori T, Takeuchi D, Ichikawa T, Ando Y. Takano Y, et al. Among authors: ando y. Endocrine. 2026 Jul 15;91(1):238. doi: 10.1007/s12020-026-04714-4. Endocrine. 2026. PMID: 42455276 Free PMC article.

4

Machine Learning-Assisted Development of High-Performance Ethanol Synthesis Catalysts via CO₂ Hydrogenation.

Du P, Ait El Fakir A, Mine S, Yang B, Pan H, He C, Dostagir NHM, Ando Y, Fischer JWA, Anzai A, Allison G, Toyoshima R, Kondoh H, Zhou W, Copéret C, Takigawa I, Shimizu KI, Toyao T. Du P, et al. Among authors: ando y. J Am Chem Soc. 2026 Jul 14. doi: 10.1021/jacs.6c06886. Online ahead of print. J Am Chem Soc. 2026. PMID: 42444444

5

Guidelines for the management of hereditary ATTR amyloidosis 2026.

Sekijima Y, Ueda M, Berk JL, Obici L, Witteles RM, Planté-Bordeneuve V, Weiler M, Fontana M, Cruz MW, Coelho T, Ericzon BG, Garcia-Pavia P, Beirão J, Wixner J, Lobato L, Ando Y, Merlini G, Maurer MS. Sekijima Y, et al. Among authors: ando y. Amyloid. 2026 Jul 9:1-26. doi: 10.1080/13506129.2026.2695368. Online ahead of print. Amyloid. 2026. PMID: 42423415 Review.

6

Probing anharmonic and heterogeneous carrier dynamics across sublattice melting in a minimal model superionic conductor.

Niyogi S, Nakamura T, Kobayashi G, Ando Y, Kawasaki T. Niyogi S, et al. Among authors: ando y. Proc Natl Acad Sci U S A. 2026 Jul 14;123(28):e2605867123. doi: 10.1073/pnas.2605867123. Epub 2026 Jul 7. Proc Natl Acad Sci U S A. 2026. PMID: 42412935 Free PMC article.

7

Clinical Outcomes of Endoscopic Full-Thickness Resection Versus Laparoscopic and Endoscopic Cooperative Surgery: A Propensity Score-Matched Comparative Study.

Ando Y, Uedo N, Furukawa K, Sawada A, Hirasawa K, Ohki A, Takeuchi H, Abe N, Kuwabara Y, Kishimoto K, Myashiro I, Ono H. Ando Y, et al. Dig Endosc. 2026 Jul;38(7):e70225. doi: 10.1111/den.70225. Dig Endosc. 2026. PMID: 42412064

8

Total Syntheses of BE-54238A and -B.

Kawai K, Ohmori K, Ando Y. Kawai K, et al. Among authors: ando y. Org Lett. 2026 Jul 17;28(28):8788-8792. doi: 10.1021/acs.orglett.6c02049. Epub 2026 Jul 3. Org Lett. 2026. PMID: 42396846

9

Neural stem cells as potential mediators of prenatal dietary stress through epigenetic mechanisms.

Kageyama I, Yamada H, Yamazaki M, Wakasugi T, Kamiya Y, Ohshiro M, Ito M, Tsuboi Y, Watanabe T, Mizuno G, Ando Y, Ishikawa H, Suzuki K, Ohashi K, Munetsuna E. Kageyama I, et al. Among authors: ando y. Stem Cell Reports. 2026 Jul 14;21(7):102996. doi: 10.1016/j.stemcr.2026.102996. Epub 2026 Jul 2. Stem Cell Reports. 2026. PMID: 42392085 Free article.

10

NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.

Ikehara T, Otsu H, Tobo T, Hosoda K, Abe T, Hashimoto M, Nakano Y, Dairaku K, Ono Y, Miyata Y, Matsumoto C, Tatsumi T, Higuchi S, Ofuchi T, Tsujimoto A, Ando Y, Hu Q, Yonemura Y, Shimizu A, Masuda T, Soejima Y, Mimori K. Ikehara T, et al. Among authors: ando y. Cancer Sci. 2026 Jun 30. doi: 10.1111/cas.70456. Online ahead of print. Cancer Sci. 2026. PMID: 42374986 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,021 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,021 results

Results by year